Interview with Sirirurg Songsivilai, Executive Director, NANOTEC
As one of the leading figures of nanotechnology in Thailand, would you introduce yourself to our readers? I am a researcher by training. I hold a medicine degree and PhD…
The main role of the Thai FDA is to protect consumers’ health, especially, to ensure safety, quality and efficacy of health products within its remit. These include: foods, drugs, psychotropic substances, narcotics, medical devices, volatile substances, cosmetics and hazardous substances available in the country. This has to be implemented in accordance with national legislation and international agreements as follows:
By law, certain important issues are decided by committees, whose members, all experts in their fields, are appointed by the Minister of Public Health. Currently, there are six committees : Drugs, Food, Cosmetics, Narcotics, Psychotropic Substances and Medical Devices.
There are two committees whose members are appointed by the other ministries. They are the Committee on the Prevention of Abuse of Volatile Substances appointed by two ministers (Industry and Public Health), and the Hazardous Substance Committee appointed by three ministers (Public Health, Industry and Agriculture).
At the national level, the Cabinet appoints three committees: the National Drug Committee, the National Food Committee and the National Chemical Safety Committee. The national committees are mainly assigned policy and development issues and collaborative action with other agencies to facilitate the implementation of the food, drug and chemical safety program as well as the control system.
Contact details
Address:
No. 88/24 , Tiwanon Road , Muang, Nonthaburi , 11000 , 11000
Tel: +66 02 590 7000
As one of the leading figures of nanotechnology in Thailand, would you introduce yourself to our readers? I am a researcher by training. I hold a medicine degree and PhD…
Practical Law Company nominated TILLEKE & GIBBINS the “Leading” Life Sciences firm in Thailand The nomination was based on firm and lawyer track records – could you describe what makes…
Novo Nordisk is one of the very few pharmaceutical multinationals that have a strong focus on one therapeutic area. Although the company has a presence in other disease areas, diabetes…
Dr Ammelburg, you have been working for Roche for more than 25 years now, time essentially spent between your home country Germany and Thailand. After more than 10 years spent…
You are General Manager for Thailand and Vietnam; two markets that certainly interest companies but at a very different stage of development. What are according to you the main differences…
Mr. Ammelburg of Roche described Thailand as a very difficult and different market and according to PReMA figures there was only 2 percent growth last year. Nevertheless, global projections rank…
PReMa was established in 2004 after a period of transformation to represent the growing role of its members, research-based companies. To begin with, could you explain us the main milestones…
TPMA is the main association bringing together the local manufacturers in Thailand. What do you consider to have been the main milestones and achievements since your inception? We haven’t reached…
Thailand might already have become a medical tourism destination but the country still needs to sort out serious issues on its local market as the country healthcare system is largely…

See our Cookie Privacy Policy Here